ArticleQuality & quantity2022
The relay for human longevity: country-specific contributions to the increase of the best-practice life expectancy.
Article in Quality & quantity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Lifespan variation during mortality transition in Bangladesh: evidence from a local surveillance and global estimates.Population health metrics · 2026Article
- The decline of 'Deaths of Despair' in Italy: unveiling this phenomenon in a new context.Population health metrics · 2026Article
- Multi-country clustering-based forecasting of healthy life expectancy.Quality & quantity · 2023Article
- Effective Use of Plant Proteins for the Development of "New" Foods.Foods (Basel, Switzerland) · 2022Review
- Stochastic mortality forecasts for Bangladesh.PloS one · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the long-term dynamics of longevity by taking into account the specific contribution of each country, and how this has changed over time, thus highlighting different timing and speeds of the evolution of life expectancy among the low-lowest mortality countries. Leveraging on quantile regression, we analyze the specific position of countries that have recorded the maximum (BPLE) and second-best life expectancy value at least once in the period 1960-2014, both at ages 0 and 65. Moving in this direction, the purpose of our contribution is to provide new perspectives on the untracked behavior that may be overshadowed by the maximum longevity levels. Our results provide a comprehensive picture of the different phases and transitions experienced by developed countries in the evolution of life expectancy that has led to a continuous increase in the BPLE. This study is a prominent practice in detecting untracked behaviors, providing imminent onsets on the maximum and sub-maximum values, thus contributing to new clues for future longevity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.